Centessa Pharmaceuticals plc
NASDAQCentessa Pharmaceuticals enters the week with its most extreme options positioning in a year, even as the lending market remains unusually relaxed — a rare divergence that frames the stock's near-term setup. The sharpest signal this week is in options. The put/call ratio jumped to 7.60 on Tuesday, a new 52-week high and almost four standard deviations above its 20-day mean of 6.06…
Snapshot as of 18 Jun 2026
Centessa Pharmaceuticals enters the week with its most extreme options positioning in a year, even as the lending market remains unusually relaxed — a rare divergence that frames the stock's near-term setup. The…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CNTA — free to start on ORTEX.
Sign up for free →Open CNTA on ORTEX